Company news
Artrya Limited (ASX:AYA) news
Artrya Limited news releases on 6ix. Latest, Oct 1, 2026: Huntsville Hospital Health System Commercial Agreement
Press releases & updates
Huntsville Hospital Health System Commercial Agreement
October 1, 2026
S&P DJI Announces September 2026 Quarterly Rebalance
September 4, 2026
FY26 Financial Results and Operational Update Presentation
August 31, 2026
Appendix 4E and Annual Report to Shareholders
August 18, 2026
June Quarterly Activities Report and Appendix 4C
July 28, 2026
Northeast Georgia Health System goes live with Salix
July 22, 2026
March Quarterly Activities Report and Appendix 4C
April 29, 2026
Update - S&P DJI March 2026 Rebalance of the All Ordinaries
March 10, 2026
S&P DJI Announces March 2026 Quarterly Rebalance
March 6, 2026
Appendix 4D and Interim Financial Report
February 25, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
Cone Health Becomes Third U.S. Customer
December 22, 2025
First Revenues from Salix Coronary Plaque Module
December 11, 2025
Second US Commercial Customer - Northeast Georgia
December 7, 2025
S&P DJI Announces December 2025 Quarterly Rebalance
December 5, 2025
SAPPHIRE Study Expands With Inclusion of Ascension
November 12, 2025
Mass General Brigham to Participate in SAPPHIRE Study
November 4, 2025
Completion of Placement and Cleansing Notice
October 30, 2025
Completion of Share Purchase Plan
October 3, 2025
Successful A$75 million placement and launch of SPP
September 8, 2025
Trading Halt
September 4, 2025
FDA clearance of Salix® Coronary Plaque module
August 21, 2025
FDA clearance of Salix Coronary Plaque module
August 20, 2025
Appendix 4E and Annual Financial Statements
August 20, 2025
AYA Signs US$0.6m Five Year Contract with Tanner Health
July 9, 2025
Artrya Leadership Transition
June 30, 2025
Artrya Secures Contract with Lumas Imaging
March 31, 2025
Artrya Secures FDA Clearance for Salix Coronary Anatomy
March 27, 2025
Investor Presentation
February 13, 2025
Successful A$15m Placement
February 13, 2025
AYA Secures Multi-Year Contract with Sonic Healthcare
February 12, 2025
Response to ASX Price Query
January 16, 2025
Successful $A5 Million Placement
November 11, 2024
Response to Price and Volume Query
October 21, 2024
Appendix 4E and Annual Financial Statements June 2024
August 29, 2024
AYA on track for FDA application submission following Q-sub
August 20, 2024
Five year Strategic Agreement with Cone Health
June 10, 2024
Artrya Commences Commercial Operations in Australia
April 1, 2024
Strategic Commercial Agreement with Tanner Health System
March 12, 2024
Appendix 4D & Interim Financial Report
February 28, 2024
Quarterly Activities and Cashflow Report
January 31, 2024
Strategic Commercial Partnership Agreement
November 19, 2023
Response to ASX Query
November 2, 2023
Quarterly Activity Report and Appendix 4C
October 18, 2023
Appendix 4E and Annual Financial Report - 30 June 2023
August 31, 2023
Quarterly Activity Report and Appendix 4C-June 2023
July 23, 2023
Company Presentation - MST Digital Health Forum
June 12, 2023
AYA Conducts Successful Q-Submission Meeting with FDA
June 9, 2023
Artrya Lodges Key Submission in FDA Process
May 2, 2023
Quarterly Activity Report and Appendix 4C-March 2023
April 18, 2023